Related Experiment Video
Updated: Jun 22, 2026
Severe Burn Injury in a Swine Model for Clinical Dressing Assessment
Published on: November 6, 2018
Longitudinal changes in plasma Transforming growth factor beta-1 and post-burn scarring in children
Patricia Rorison1, Alison Thomlinson, Zahid Hassan
1Birmingham Childrens' Hospital, Birmingham, United Kingdom.
Insights
Early plasma levels of Transforming growth factor beta-1 (TGFβ1) may predict hypertrophic scarring in children after burns. A lack of early TGFβ1 increase indicates higher risk, allowing for timely interventions to improve burn scar outcomes.
Area of Science:
- Biochemistry
- Dermatology
- Pediatric Medicine
Background:
- Transforming growth factor beta-1 (TGFβ1) is crucial for wound healing but linked to fibrosis.
- Hypertrophic scarring in children, often caused by burns, leads to functional and psychological issues.
- Predicting scar development is vital for effective pediatric burn management.
Purpose of the Study:
- To investigate the longitudinal relationship between plasma TGFβ1 levels and burn wound healing in children.
- To determine if early TGFβ1 levels can predict the development of hypertrophic scarring post-burn.
- To identify potential biomarkers for early risk assessment of severe scarring in pediatric burn survivors.
Main Methods:
- Longitudinal study tracking plasma TGFβ1 levels in pediatric burn patients.
- Correlation analysis of early post-burn TGFβ1 concentrations with scar quality outcomes.
- Comparison of TGFβ1 profiles between patients with good scar healing and those developing hypertrophic scars.
Main Results:
- Plasma TGFβ1 levels significantly increased in the early weeks post-burn in children who healed well.
- Children who developed hypertrophic scars showed an absence of this early TGFβ1 increase.
- Early post-burn plasma TGFβ1 dynamics differ between good and poor scar healing outcomes.
Conclusions:
- The early systemic response of TGFβ1 after a burn may serve as an indicator for hypertrophic scar risk in children.
- Monitoring early plasma TGFβ1 levels could identify at-risk pediatric patients for targeted interventions.
- This approach may help reduce scar-related morbidity in pediatric burn survivors through early management.
Abstract:
Transforming growth factor beta1, a multifunctional growth factor, plays a pivotal role in wound healing and has been shown to accelerate impaired wound healing. However, high systemic levels of Transforming growth factor beta1 have generally been associated with fibrotic disease processes such as myelofibrosis and pulmonary fibrosis. Hypertrophic scarring occurring during childhood interferes with growth, impairs the function and causes immense psychological and aesthetic problems. Burns is the leading cause of hypertrophic scarring. We studied the longitudinal relationship between plasma Transforming growth factor beta-1 and post-burn wound healing and scarring in children. We discovered that the plasma levels of Transforming growth factor beta-1 rapidly increased to significantly higher levels in the first two weeks post-injury and fell thereafter, in patients who healed with good quality scars post-burn. By contrast, the increase in plasma TGFbeta1 levels in the early stages after-burn, was noticeably absent in patients who developed hypertrophic scarring. We propose that this change in the systemic levels of TGFbeta1 early after the burn may be used as an indicator of patients at risk of developing hypertrophic burn scars. This group of patients could then be targeted for early pharmacological/physical interventions to reduce/prevent scar-related morbidity in burn survivors.
Related Concept Videos
01:24Healing II: Complications
01:16TGF - β Signaling Pathway
01:19Clinical Applications of Epidermal Stem Cells